Suppr超能文献

摄取2在离体大鼠心脏儿茶酚胺的非神经元代谢中的作用。

The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart.

作者信息

Lightman S L, Iversen L L

出版信息

Br J Pharmacol. 1969 Nov;37(3):638-49. doi: 10.1111/j.1476-5381.1969.tb08502.x.

Abstract
  1. (+/-)-(3)H-NA and labelled metabolites of NA were estimated in rat hearts after perfusion with various concentrations of NA in the range 0.01-50.0 mug/ml. Labelled metabolites of NA accounted for only a small proportion of the total uptake of radioactivity at low perfusion concentrations, but accounted for 50% of the total uptake at 1 mug NA/ml., thereafter declining to progressively smaller proportions at higher perfusion concentrations.2. If the formation of labelled metabolites of (3)H-NA was blocked by a combination of monoamine oxidase and catechol-O-methyl transferase inhibitors, the accumulation of unchanged (3)H-NA was doubled when hearts were perfused with 1 mug NA/ml.3. In hearts perfused with 0.5 mug NA/ml., an accumulation of unchanged (3)H-NA was demonstrated in the presence of a combination of metabolic inhibitors and metaraminol. This appeared to be due to Uptake(2), since the accumulation of NA under these conditions could be prevented by a low concentration of normetanephrine.4. Phenoxybenzamine prevented extraneuronal uptake (Uptake(2)) and metabolism of (3)H-NA with an estimated ID50 of 2.5 muM. The inhibition of Uptake(2) by phenoxybenzamine (2.0 muM) was diminished at very high NA concentrations, suggesting that the drug may act competitively with NA.5. It was concluded that Uptake(2) operates at all catecholamine concentrations in the rat heart, but that in the lower range (less than 2.5 mug/ml. for NA and less than 0.75 mug/ml. for adrenaline) any catecholamine taken up by this process is rapidly metabolized. Thus the accumulation of unchanged amine is seen only at high perfusion concentrations.6. The relevance of these results to an understanding of the possible physiological and pharmacological importance of Uptake(2) is discussed.
摘要
  1. 在大鼠心脏用0.01 - 50.0微克/毫升范围内的不同浓度去甲肾上腺素(NA)灌注后,对(±) - (3)H - NA及NA的标记代谢产物进行了测定。在低灌注浓度时,NA的标记代谢产物仅占放射性总摄取量的一小部分,但在1微克NA/毫升时占总摄取量的50%,此后在较高灌注浓度下占比逐渐减小。

  2. 如果(3)H - NA标记代谢产物的形成被单胺氧化酶和儿茶酚 - O - 甲基转移酶抑制剂联合阻断,当心脏用1微克NA/毫升灌注时,未变化的(3)H - NA的积累量会增加一倍。

  3. 在心脏用0.5微克NA/毫升灌注时,在代谢抑制剂和间羟胺联合存在的情况下,证明有未变化的(3)H - NA积累。这似乎是由于摄取2(Uptake(2)),因为在这些条件下NA的积累可被低浓度的去甲变肾上腺素阻止。

  4. 酚苄明可阻止(3)H - NA的非神经摄取(摄取2)和代谢,估计半数抑制浓度(ID50)为2.5微摩尔。在非常高的NA浓度下,酚苄明(2.0微摩尔)对摄取2的抑制作用减弱,表明该药物可能与NA竞争性作用。

  5. 得出的结论是,摄取2在大鼠心脏的所有儿茶酚胺浓度下均起作用,但在较低浓度范围(NA低于2.5微克/毫升,肾上腺素低于0.75微克/毫升),通过该过程摄取的任何儿茶酚胺都会迅速代谢。因此,仅在高灌注浓度下才会出现未变化胺的积累。

  6. 讨论了这些结果对于理解摄取2可能的生理和药理重要性的相关性。

相似文献

7
The fate of [3H]-(-)-noradrenaline in the perfused rat liver.灌注大鼠肝脏中[3H]-(-)-去甲肾上腺素的命运
J Auton Pharmacol. 1995 Oct;15(5):309-19. doi: 10.1111/j.1474-8673.1995.tb00397.x.
10
Errors introduced by a tritium label in position 8 of catecholamines.儿茶酚胺第8位上的氚标记所引入的误差。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):34-42. doi: 10.1007/BF00633194.

引用本文的文献

9
Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.质膜单胺转运体在脑中的表达及免疫定位
Neuroscience. 2007 May 25;146(3):1193-211. doi: 10.1016/j.neuroscience.2007.01.072. Epub 2007 Apr 3.

本文引用的文献

2
THE UPTAKE OF NORADRENALINE BY THE ISOLATED PERFUSED RAT HEART.去甲肾上腺素在离体灌注大鼠心脏中的摄取
Br J Pharmacol Chemother. 1963 Dec;21(3):523-37. doi: 10.1111/j.1476-5381.1963.tb02020.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验